This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Here's Why I Dumped Ford And Bought Colgate Palmolive

Stocks in this article: AAPLCLFMCDMSFT

The Sustained Momentum Model continues to closely track the S&P 500 performance, trailing the index by approximately 3% at month-end, and is my newest of my three Covestor Models. (The other two portfolios are the Buy and Hold, Value and Healthcare).

This model is based on my Marketocracy Model, which is a stock market "game" website that allows individual investors to develop their own strategies in investing with simulated investments that track the performance of a theoretical $1 million portfolio. I have been a Marketocracy participant since March 7, 2004.

I currently have 53 different holdings in my Marketocracy portfolio. These stocks have been selected by me on the belief that they would each outperform the overall market.

From these 53 I have chosen to include the top 11 holdings in my real Covestor account that actually in a sense mirrors my Marketocracy account.  As the top 11 holdings change in my simulated portfolio, I reflect these changes in my real-life Covestor account.

It is well known that individual investors over-trade their accounts. I am no exception. I find that my own enthusiasm grows as a stock price and the market climbs and I share in the general malaise as a holding declines in price or the overall market sells off.

To avoid this emotional roller coaster, I have set up this Covestor Model to respond in a more mechanical fashion to price changes trying very hard to take out the emotional component.  Simply put, if the stock stays in the top 11 holdings, it stays in the portfolio. It is only removed if it drops out and one of the other 42 of the stocks I track replaces it.

Since February 1, 2013, the only change has been the sale of Ford (F) which due to a price decline, found itself replaced by Colgate Palmolive (CL) which not because of any personal bias but because of the underlying strength of the stock itself muscled its way into the top 11 of the holdings.

As of this date (March 6, 2013), the 5 stocks in the wings (occupying positions 12-16) were Ford (F), Microsoft (MSFT), Apple (AAPL), McDonald's (MCD) and MWI Veterinary (MWIV).  Time will tell whether they will be included.

This model, while perhaps not as easily explained as the other, may well represent an opportunity to see if by concentrating on my strongest performing holdings, not my favorite stocks, I can manage to keep up or outperform the S&P 500.  Thus far, I am still 'in the running'.  I hope to report further positive results in the future.

The investments discussed are held in client accounts as of March 1, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable.

Robert Freedland

Robert Freedland

Robert has over 40 years of investment experience and is a full-time optical surgeon. He uses his expertise in the

null

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs